Gene · 7917
Papers1,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation. | bioRxiv | 2023 | 37808699 | PubTator, text mining | PubMed |
| A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy. | Theranostics | 2023 | 37771787 | PubTator, text mining | PubMed |
| RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy. | Biomedicines | 2023 | 37760968 | PubTator, text mining | PubMed |
| Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis. | Dig Dis Sci | 2023 | 37755606 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Proteotoxic stresses stimulate dissociation of UBL4A from the tail-anchored protein recognition complex. | Biochem J | 2023 | 37747814 | PubTator, text mining | PubMed |
| Elucidation of E3 ubiquitin ligase specificity through proteome-wide internal degron mapping. | Mol Cell | 2023 | 37738965 | PubTator, text mining | PubMed |
| Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer. | Clin Transl Med | 2023 | 37700495 | PubTator, text mining | PubMed |
| Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity. | Front Immunol | 2023 | 37675104 | PubTator, text mining | PubMed |
| Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. | Front Immunol | 2023 | 37654497 | PubTator, text mining | PubMed |
| Triaging of α-helical proteins to the mitochondrial outer membrane by distinct chaperone machinery based on substrate topology. | bioRxiv | 2023 | 37645817 | PubTator, text mining | PubMed |
| Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy. | Viruses | 2023 | 37632078 | PubTator, text mining | PubMed |
| Functional Landscape of African Swine Fever Virus-Host and Virus-Virus Protein Interactions. | Viruses | 2023 | 37631977 | PubTator, text mining | PubMed |
| Dendritic Cell-Derived Exosomes in Cancer Immunotherapy. | Pharmaceutics | 2023 | 37631284 | PubTator, text mining | PubMed |
| What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome? | Mol Cell Proteomics | 2023 | 37572790 | PubTator, text mining | PubMed |
| Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature. | Int J Mol Sci | 2023 | 37569880 | PubTator, text mining | PubMed |
| TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors. | Cancer Immunol Immunother | 2023 | 37567938 | PubTator, text mining | PubMed |
| Genomic screening of allelic and genotypic transmission ratio distortion in horse. | PLoS One | 2023 | 37556504 | PubTator, text mining | PubMed |
| Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases. | Clin Proteomics | 2023 | 37550624 | PubTator, text mining | PubMed |
| Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art. | Cancer Cell Int | 2023 | 37543612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7917/papers?page=6